Orange Book product · Generic (ANDA)
ALVIMOPAN
ALVIMOPAN
Generic (ANDA)ANDA 208295TE ABRX WATSON LABS TEVA
At a glance
Dec 19, 2019
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2019
6 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
ALVIMOPAN
Strength
12MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 208295
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of ALVIMOPAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
